SMC4 and pancreatic adenocarcinoma: SMC4 was observed to be significantly related to poorer overall survival (OS) and disease-free survival (DFS) in ACC, KICH, KIRP, LGG, PAAD and PRAD, poorer OS in LIHC, LUAD and MESO and poorer disease-free survival post-THCA (Figure 2).